Amid shifts in attitudes around family planning and contraception—and as the advent of telehealth outfits like Hims & Hers ...
ADELAIDE, Australia and RALEIGH, N.C., Nov. 4, 2024 /PRNewswire/ -- Mayne Pharma Group Limited (Mayne Pharma or the Company) (ASX: MYX), welcomes the Biden-Harris Administration's newly proposed rule ...
SAN FRANCISCO and CAPE TOWN, South Africa, April 22, 2026 (GLOBE NEWSWIRE)-- Medicines360 and Pharma Dynamics have announced the availability of AVIBELA, South Africa’s first generic levonorgestrel 52 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A former UNC scientist is ...
The Google Ventures-backed company could become the first to commercialise a reversible male contraceptive drug, provided the gel is successful in Phase III.
Shortly after Evofem picked up FDA approval for its contraceptive gel Phexxi back in 2020, the company touted the product as the "first contraceptive innovation in decades" and one that offered a new ...
The news: Mayne Pharma shares lifted in morning trade after the drug company announced that its flagship birth control pill NEXTSTELLIS will be listed on Australia’s pharmaceutical benefits scheme ...
(RTTNews) - Baltimore, Maryland-based Lupin Pharmaceuticals, Inc. has recalled 2 lots of Tydemy oral contraceptive citing out of specification or OOS test results at the 12-month stability time point, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results